Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2087)
All Articles published online
|
Feb 28, 2007 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Veillon P, Payan C, Le Guillou-Guillemette H, Gaudy C, Lunel F. Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy. World J Gastroenterol 2007; 13(8): 1195-1203 [PMID: 17451199 DOI: 10.3748/wjg.v13.i8.1195] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i8/1195.htm |
| Number | Citing Articles |
| 1 |
Sarah L. Fishman, Andrea D. Branch. The quasispecies nature and biological implications of the hepatitis C virus. Infection, Genetics and Evolution 2009; 9(6): 1158 doi: 10.1016/j.meegid.2009.07.011
|
| 2 |
Severine Margeridon-Thermet, Robert W. Shafer. Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C. Viruses 2010; 2(12): 2696 doi: 10.3390/v2122696
|
| 3 |
Nathan A. Cannon, Maureen J. Donlin, Xiaofeng Fan, Rajeev Aurora, John E. Tavis, Sheila Mary Bowyer. Hepatitis C Virus Diversity and Evolution in the Full Open-Reading Frame during Antiviral Therapy. PLoS ONE 2008; 3(5): e2123 doi: 10.1371/journal.pone.0002123
|
| 4 |
Saba Khaliq, Noreen Latief, Shah Jahan. Role of different regions of the hepatitis C virus genome in the therapeutic response to interferon-based treatment. Archives of Virology 2014; 159(1): 1 doi: 10.1007/s00705-013-1780-x
|
| 5 |
J. A.L. Short. Viral evasion of interferon stimulated genes. Bioscience Horizons 2009; 2(2): 212 doi: 10.1093/biohorizons/hzp014
|
| 6 |
Celia Perales, Rubén Agudo, Hector Tejero, Susanna C. Manrubia, Esteban Domingo, Karla Kirkegaard. Potential Benefits of Sequential Inhibitor-Mutagen Treatments of RNA Virus Infections. PLoS Pathogens 2009; 5(11): e1000658 doi: 10.1371/journal.ppat.1000658
|
| 7 |
Shinya Maekawa, Nobuyuki Enomoto. Hepatitis C Virus II. 2016; : 243 doi: 10.1007/978-4-431-56101-9_9
|
| 8 |
N. Bouzgarrou, E. Hassen, W. Mahfoudh, S. Gabbouj, E. Schvoerer, A. Ben Yahia, N. Ben Mami, H. Triki, L. Chouchane. NS5AISDR‐V3region genetic variability of Tunisian HCV‐1b strains: Correlation with the response to the combined interferon/Ribavirin therapy. Journal of Medical Virology 2009; 81(12): 2021 doi: 10.1002/jmv.21641
|
| 9 |
James Lara, Guoliang Xia, Mike Purdy, Yury Khudyakov. Coevolution of the Hepatitis C Virus Polyprotein Sites in Patients on Combined Pegylated Interferon and Ribavirin Therapy. Journal of Virology 2011; 85(7): 3649 doi: 10.1128/JVI.02197-10
|
| 10 |
P. Muñoz de Rueda, J. Casado, R. Patón, D. Quintero, A. Palacios, A. Gila, R. Quiles, J. León, A. Ruiz-Extremera, J. Salmerón. Mutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of Hepatitis C Virus Genotype 1 and Their Relationships to Pegylated Interferon-Ribavirin Treatment Responses. Journal of Virology 2008; 82(13): 6644 doi: 10.1128/JVI.02231-07
|
| 11 |
Shinya Maekawa, Nobuyuki Enomoto. Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C. Journal of Gastroenterology 2009; 44(10): 1009 doi: 10.1007/s00535-009-0126-7
|
| 12 |
Hélène Le Guillou-Guillemette, Adeline Pivert, Elise Bouthry, Cécile Henquell, Odile Petsaris, Alexandra Ducancelle, Pascal Veillon, Sophie Vallet, Sophie Alain, Vincent Thibault, Florence Abravanel, Arielle A. Rosenberg, Elisabeth André-Garnier, Jean-Baptiste Bour, Yazid Baazia, Pascale Trimoulet, Patrice André, Catherine Gaudy-Graffin, Dominique Bettinger, Sylvie Larrat, Anne Signori-Schmuck, Hénia Saoudin, Bruno Pozzetto, Gisèle Lagathu, Sophie Minjolle-Cha, Françoise Stoll-Keller, Jean-Michel Pawlotsky, Jacques Izopet, Christopher Payan, Françoise Lunel-Fabiani, Christophe Lemaire, Dimitrios Paraskevis. Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma. PLOS ONE 2017; 12(4): e0174651 doi: 10.1371/journal.pone.0174651
|
| 13 |
Ahmed El‐Shamy, Motoko Nagano‐Fujii, Noriko Sasase, Susumu Imoto, Soo‐Ryang Kim, Hak Hotta. Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy†. Hepatology 2008; 48(1): 38 doi: 10.1002/hep.22339
|
| 14 |
Odile Petsaris, Sophie Vallet, Hélène Le Guillou-Guillemette, Pascal Veillon, Stéphanie Gouriou, Georges Barbier, Jean-Baptiste Nousbaum, Philippe Saliou, Gisèle NKontchou, Jean-Claude Trinchet, Francoise Lunel-Fabiani, Christopher Payan. Duplication of the V3 domain in hepatitis C virus (1b) NS5A protein: Clonal analysis and physicochemical properties related to hepatocellular carcinoma occurrence. Journal of Clinical Virology 2016; 74: 19 doi: 10.1016/j.jcv.2015.11.011
|
| 15 |
Hamed Esmaeil Lashgarian, Ali Valibeik, Abdolrazagh Marzban, Maryam Karkhane, Kiana Shahzamani. The Relationship Between HCV-NS5A Gene Mutations and Resistance to Combination Therapy in Patients with HCV- Genotype 1-B. Reports of Biochemistry and Molecular Biology 2021; 10(2): 233 doi: 10.52547/rbmb.10.2.233
|
| 16 |
Daisuke Sasaki, Kazuyuki Sugahara, Naoko Inokuchi, Katunori Yanagihara, Hiroo Hasegawa, Sayaka Mori, Yasuaki Yamada, Shimeru Kamihira. Screening for genetic heterogeneity in the interferon sensitivity determining region of the hepatitis C virus genome by polymerase chain reaction with melting curve analysis. Clinical Chemistry and Laboratory Medicine 2008; 46(7) doi: 10.1515/CCLM.2008.186
|
| 17 |
Fernanda de Mello Malta, José Eymard Moraes de Medeiros-Filho, Raymundo Soares de Azevedo, Luzia Gonçalves, Luiz Caetano da Silva, Flair José Carrilho, João Renato Rebello Pinho. Sequencing of E2 and NS5A regions of HCV genotype 3a in Brazilian patients with chronic hepatitis. Memórias do Instituto Oswaldo Cruz 2010; 105(1): 92 doi: 10.1590/S0074-02762010000100014
|
| 18 |
H. Le Guillou-Guillemette, A. Ducancelle, S. Bertrais, C. Lemaire, A. Pivert, P. Veillon, E. Bouthry, S. Alain, V. Thibault, F. Abravanel, A.R. Rosenberg, C. Henquell, E. André-Garnier, O. Petsaris, S. Vallet, J.B. Bour, Y. Baazia, P. Trimoulet, P. André, C. Gaudy-Graffin, D. Bettinger, S. Larrat, A. Signori-Schmuck, H. Saoudin, B. Pozzetto, G. Lagathu, S. Minjolle-Cha, F. Stoll-Keller, J.M. Pawlotsky, J. Izopet, C. Payan, F. Lunel-Fabiani. Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients. Journal of Clinical Virology 2015; 69: 203 doi: 10.1016/j.jcv.2015.06.096
|
| 19 |
Kazuaki Chayama, C Nelson Hayes. Hepatitis C virus: How genetic variability affects pathobiology of disease. Journal of Gastroenterology and Hepatology 2011; 26(s1): 83 doi: 10.1111/j.1440-1746.2010.06550.x
|
| 20 |
Carolin Wohlfarth, Thomas Efferth. Natural products as promising drug candidates for the treatment of hepatitis B and C. Acta Pharmacologica Sinica 2009; 30(1): 25 doi: 10.1038/aps.2008.5
|